VANESSA BRIDGEMAN: Open Payments
NPI 1063962892 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 31 payments from 13 companies in 2025. Trend: 2023 $996 · 2024 $1,277 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $200 |
| Phathom Pharmaceuticals, Inc. | 6 | $135 |
| Medtronic, Inc. | 1 | $81 |
| ABBVIE INC. | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
Products named: VOQUEZNA, INTERSTIM, DUPIXENT, TREMFYA, CREON, EOHILIA, RINVOQ, TERLIVAZ.
Industry payments across GA — which companies pay providers there.
